Download full report with analyst certification and important disclosures
Jan 26 2022, 07:35 GMT
Foods
Strong ADM Nutrition growth underpins investor day strategy
- Sectors : Foods
- Companies : Givaudan | Kerry Group | Symrise | DSM-Firmenich
Ratings
Ratings and price correct at time of issue
| Company | Rating | Date | Previous Rating | Date | Closing Price |
|---|---|---|---|---|---|
| DSM-Firmenich | OUTPERFORM | 09/10/20 | Neutral | 13/02/20 | 16535c |
| Givaudan | OUTPERFORM | 24/03/20 | Neutral | 21/06/12 | 403900chf |
| Kerry Group | OUTPERFORM | 30/06/09 | N/A | N/A | 10990c |
| Symrise | OUTPERFORM | 24/03/20 | Neutral | 15/01/19 | 10835c |
DAVY VIEW
ADM’s Q4 results confirm sustained growth across its Nutrition platform. Revenue growth of 19% places ADM’s Nutrition business in the top decile of the sector. Despite cost headwinds, ADM maintained margin in the quarter. Its revenue and profit outlook for the Nutrition segment remains positive.
